Efferent Labs, Inc.

About:

Efferent Labs is an award winning biotechnology company focused on biosensor systems for the life sciences

Website: https://www.efferentlabs.com/

Twitter/X: efferentlabs

Top Investors: 43North, Z80 Labs Technology Incubator, Excell Partners

Description:

Efferent Labs, Inc. is an award winning biotechnology company focused on biosensor systems for life sciences. Our proprietary technology is showcased in the CytoComm™ Living Biosensor System, an in vivo, real time monitoring system for biological signaling and cellular responses. CytoComm™ is unique as it employs living cell lines, a powerful tool to assess cellular function in vivo. The system transmits live data through the cloud to our data acquisition and analysis software, providing real-time information to researchers and clinicians. The CytoComm™ Biosensor Platform has multiple applications including preclinical R&D, clinical R&D, oncology, cardiology, and metabolic diseases. For more information, please see our website, www.efferentlabs.com

Total Funding Amount:

$900000

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Buffalo, New York, United States

Founded Date:

2013-10-01

Contact Email:

info(AT)efferentlabs.com

Founders:

Spencer Rosero, W.K. (Bill) Rader

Number of Employees:

1-10

Last Funding Date:

2016-08-26

IPO Status:

Private

Industries:

© 2025 bioDAO.ai